Use of ACEi/ARBs, SGLT-2 inhibitors and MRAs can help us reach the therapeutic ceiling in CKD

  • Published on 07/02/2024
  •  Reading time: 4 min.

Pantelis Sarafidis

1st Department of Nephrology, Aristotle University of Thessaloniki, Hippokration Hospital, Greece

Correspondence to: Pantelis A. Sarafidis; E-mail: psarafidis11@yahoo.gr

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Nephrology

Receive our newsletter to stay up to date with the latest news in Nephrology

More articles

From peer-reviewed journals in Nephrology